Androgen effects on bone and muscle

Fertility and Sterility

Volumn 77, Issue SUPPL. 4, 2002, Pages 34-41

  Notelovitz, Morris ^a,b  

^a Adult Women's Medicine   (United States)

^b S Medicine   (United States)

Author keywords

Androgens; BMD; DHEA; Estrogen; Muscle mass and strength; Osteoblasts; Osteoclasts; Osteocytes; Testosterone

Indexed keywords

ANDROGEN; CYTOKINE; ESTROGEN; GESTAGEN; GROWTH FACTOR; PRASTERONE; SEX HORMONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR;

ADOLESCENT; AGE; AROMATIZATION; BONE; BONE DENSITY; BONE MATRIX; BONE MINERALIZATION; BONE REMODELING; BONE STRENGTH; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CONFERENCE PAPER; ENDOMETRIUM; ENZYME ACTIVITY; HIRSUTISM; HORMONAL THERAPY; HORMONE ACTION; HORMONE METABOLISM; HUMAN; MUSCLE; MUSCLE MASS; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; OVARY POLYCYSTIC DISEASE; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BINDING; ANIMAL; FEMALE; METABOLISM; PHYSIOLOGY; REVIEW;

ANDROGENS; ANIMALS; BONE AND BONES; BONE DENSITY; BONE REMODELING; ESTROGENS; FEMALE; HUMANS; MUSCLES; OSTEOBLASTS; OSTEOCLASTS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN;

EID: 0036242917     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0015-0282(02)02968-0     Document Type: Conference Paper

References (56)

1. Is BMU-coupling a strain-regulated phenomenon? A finite element analysis
2. Bone remodeling and bone loss: Understanding the pathophysiology of osteoporosis
3. Cellular responses to mechanical loading in vitro
4. Physical activity, nutrition, bone density and osteoporosis
5. Role of nitric oxide and prostaglandins in mechanically induced bone formation
6. Weight bearing activity during youth is a more important factor for peak bone mass than calcium intake
7. Cancellous bone remodeling in type 1 (postmenopausal) osteoporosis: Quantitative assessment of rates of formation, resorption and bone loss at tissue and cellular levels
8. Estrogen and the risk of breast cancer
9. Failure of isolated rat tibial periosteal cells to 5α reduce testosterone to 5α dihydrotestosterone
10. The localization of androgen receptors in bone
11. Skeletal site dependent expression of the androgen receptor in human osteoblastic cell populations
12. Nuclear receptor coregulators: Cellular and molecular biology
13. Rapid signaling by androgen receptor in prostate cancer cells
14. Regulation of interleukin-6 osteoclastogenesis and bone mass by androgens: The role of the androgen receptor
15. The presence of a dehydroandrosterone-specific receptor binding complex in murine T cells
16. Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro
17. Androgenic regulation of bone mass in women: A review
18. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone
19. Androgens directly stimulate proliferation of bone cells in vitro
20. Transforming growth-factor β gene family members and bone
21. Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells
22. Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvaria
23. Bone mineral density, androgens and the polycystic ovary: The complex and controversial issue of androgenic influence in female bone
24. Effect of excess endogenous androgens on bone density in young women
25. Sex steroids and bone density in premenopausal and perimenopausal women
26. Total free estrogens and androgens in postmenopausal women with hip fracture
27. Low bioavailable testosterone levels predict future height loss in postmenopausal women
28. Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group
29. Dehydroepiandrosterone replacement for patients with adrenal insufficiency
30. Bone mineral density in women with idiopathic hirsutism
31. Bone mass in hirsute women with androgen excess
32. Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea
33. Antiandrogen treatment with spironolactone and linestrenol decreases bone mineral density in eumenorrheic women with androgen excess
34. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women
35. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens
36. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms and lipid-lipoprotein profiles in surgical menopause
37. A two year double-blind comparison of estrogen-androgen and conjugated estrogen in surgically postmenopausal women. Effects on bone mineral density, symptoms and lipid profiles
38. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality
39. The effects of plasma estradiol levels on increases in vertebral and femoral bone density following therapy with estradiol and estradiol with testosterone pellets
40. Evidence for progesterone receptors in human osteoblast-like cells
41. Progesterone and dexamethasone stimulate proliferation and differentiation of osteoprogenitors for adipocytes and macrophages in cell populations derived from adult rat vertebrae
42. Spinal bone loss and ovulatory disturbances
43. Cyclic medroxyprogesterone treatment increases bone density: A controlled trial in active women with menstrual cycle disturbances
44. Effects of hormone therapy on bone mineral density. Results from the post-menopausal estrogen/progesterone intervention (PEPI) trial
45. The comparative effect on bone density, endometrium and lipids of continuous hormones as replacement therapy (Chart Study)
46. Uncoupling of bone formation and resorption by combined oestrogen and progestogen therapy in postmenopausal osteoporosis
47. Prevention of bone mineral loss in postmenopausal women by norethindrone
48. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate
49. Tibolone and its effect on bone: A review
50. Muscle strength, bone mass and age-related bone loss
51. Influence of muscle activity of the forces of the femur: Comparison between in vivo measurements and calculation
52. Effect of resistance exercise training on bone formation and resorption in young male subjects assessed by biomarker of bone metabolism
53. The relationship of menopause to skeletal and muscle mass
54. Muscle weakness in women occurs at an earlier age than men, but strength is preserved by hormone replacement therapy
55. Cross-sectional study of muscle strength and bone mineral density in a population of 106 women between the ages of 44 and 87 years: Relationship with age and menopause
56. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in post menopausal women